CD79A and autoimmune polyendocrinopathy: The first two problems are solved because most of the studies published in recent years use contrasting systems and confirm the usefulness of this isotype in the diagnosis of patients with clinical APS.[37, 38] Our work also contributes to solving the third problem: defining the significance of isolated positivity of IgA with aB2GPI in asymptomatic population.